Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
US8287878B2 · kind B2 · utility
0Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2005 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Jan 22, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV). More particularly, the invention relates to the identification of combined mutation classes which synergistically attenuate the pathogenicity of VSV vectors in mammals and immunogenic compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.